Lead Product(s): Undisclosed
Therapeutic Area: Immunology
Highest Development Status: Discovery Product Type: Small molecule
Partner/Sponsor/Collaborator: Bayer HealthCare
Deal Size: $270.4 million Upfront Cash: Undisclosed
Deal Type: Licensing Agreement March 23, 2020
The collaboration aims to discover new drug candidates for the treatment of lung diseases, cardiovascular diseases and other inflammatory diseases.